Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Analgesia in PACU: Intravenous Opioids

Author(s): G. Conti, R. Costa, A. Pellegrini, A. Craba and F. Cavaliere

Volume 6 , Issue 7 , 2005

Page: [767 - 771] Pages: 5

DOI: 10.2174/138945005774574407

Price: $65

Abstract

Critically ill patients, particularly those under mechanical ventilation, require analgo-sedation to control noxious stimuli and enhance comfort. Despite their harmful side effects, such as respiratory depression, physical dependance and difficult arousal, opioids are effective in providing a good level of analgesia and comfort. Traditional opioids (morphine and fentanyl) have been shown effective in providing analgesia; however, the respiratory adverse effects and their pharmacokinetics, with an high risk of accumulation, limits their use, especially for a long-term sedation. In the last decade, new synthetic opioids with limited side effects and favourable pharmacokinetics profile, such as Sufentanil and Remifentanil, have been investigated to evaluate their efficacy in mitigating pain and enhancing comfort in critically ill patients.

Keywords: analgo-sedation, opioids, morphine, fentanyl, sufentanil, remifentanil


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy